Nomura Holdings’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Nomura Holdings's DGX Position: Q1 2026 in Review
Nomura Holdings increased its Quest Diagnostics (DGX) stake by 326% in Q1 2026, buying an estimated $800K and bringing the position to 5,382 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1142.
Nomura Holdings first reported a position in DGX in Q2 2013 and has held it in 32 quarters since. The position peaked at $9.9M in Q4 2013. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Nomura Holdings held 5,382 shares of Quest Diagnostics worth $1.05M as of Q1 2026.
- Nomura Holdings bought 4,120 Quest Diagnostics shares in Q1 2026, an estimated $800K.
- Quest Diagnostics made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1142 holding.
- Nomura Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 32 quarters since.
- Nomura Holdings's Quest Diagnostics position peaked at $9.9M in Q4 2013.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.